Full Name
Art Tipton
Job Title
Company or Organization
Vulcan Gray
Speaker Bio
Arthur J. Tipton, Ph.D., currently serves as a principal Vulcan Gray, a consulting company advising startups primarily in the biotech sector. Previously, he served as the president and CEO of Southern Research from 2013 - 2019. He also worked in the pharmaceutical and biotech industries for 25 years, participating in the growth aspects of three start-up companies, one that went public and two acquired by public companies. The company he founded in 2005 as an SR spin-out company – Brookwood Pharmaceuticals – was acquired by SurModics in August 2007, then by Evonik in November 2011. At Evonik, Tipton served as senior vice president of the Birmingham division and also led the company’s global drug delivery program.

From 1993 to 2004, Tipton worked in roles of increasing responsibility at Durect Corporation, including that of senior vice president of biodegradable systems, chief operating officer, vice president of its wholly-owned subsidiary Southern BioSystems, and president of Birmingham Polymers. He was with Atrix Laboratories (now part of QLT Inc.) from 1988 until 1993, as manager of polymer science and senior polymer chemist.

Tipton has served on multiple boards including EDPA, BBA, Innovation Depot and the external advisory Board to both the School of Business and School of Engineering Department at University of Alabama at Birmingham (UAB). His previous Executive Board Roles include President, Treasurer and Board Member of the Controlled Release Society, and Chairman and Board Member of Biotech Association of Alabama (BioAlabama). Additional Board roles include the Society for Biomaterials, the American Institute of Medical and Biological Engineers, Southeastern Medical Device Association, TechBirmingham, the Birmingham Venture Club, and the corporate boards of Brookwood Pharmaceuticals and Southern BioSystems.

He has led or participated in multiple transactions, including sell-side and buy-side acquisitions and licenses. Tipton has 42 issued U.S. patents, 30 published U.S. patent applications, and numerous foreign equivalents, with more than 75 presentations and publications.

He was elected a fellow of American Institute of Medical and Biological Engineers (the top 2% of medical and biological engineers) in 2008 and into the Inaugural College of Fellows of Controlled Release Society (CRS) in 2009 and was awarded the CRS Distinguished Service Award in 2012. In 2013, he was inducted as a fellow into the National Academy of Inventors. Tipton is a 2015 graduate of the FBI Citizens Academy.

Tipton earned a doctorate in polymer science and engineering from the University of Massachusetts, Amherst and a Bachelor of Science in chemistry from Spring Hill College.
Art Tipton